Dr. Brad J. Herskowitz, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Miami, Lm Miller School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 300
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Miami, Lm Miller School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
FL license ME81159
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Hospital of Miami Miami, FL
- South Miami Hospital Miami, FL
- Doctors Hospital Coral Gables, FL
Medical groups
- Neuroscience Consultants LLP (115 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 300
- Services billed
- 15,499
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 9,500 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 259 | 154 |
| Annual depression screening, 5 to 15 minutes | 55 | 55 |
| Established patient office or other outpatient visit, 20-29 minutes | 47 | 42 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 45 | 44 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 44 | 24 |
| New patient office or other outpatient visit, 45-59 minutes | 33 | 33 |
| Established patient office or other outpatient visit, 40-54 minutes | 29 | 27 |
| New patient office or other outpatient visit, 30-44 minutes | 22 | 22 |
| Nerve conduction, 5-6 studies | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Miami, FL | 98 |
| Levetiracetam Other prescribers in Miami, FL | 75 |
| Topiramate Other prescribers in Miami, FL | 38 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Miami, FL | 37 |
| Sumatriptan Succinate Other prescribers in Miami, FL | 36 |
| Quetiapine Fumarate Other prescribers in Miami, FL | 36 |
| Rexulti (brexpiprazole) Other prescribers in Miami, FL | 28 |
| Primidone Other prescribers in Miami, FL | 26 |
| Pregabalin Other prescribers in Miami, FL | 25 |
| Duloxetine Hcl Other prescribers in Miami, FL | 23 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 35 companies reported 197 payments worth $56,692 in total to this clinician.
| Lilly USA, LLC | $26,879 |
|---|---|
| AbbVie Inc. | $10,922 |
| Axsome Therapeutics, Inc. | $10,009 |
| Pfizer Inc. | $6,654 |
| UCB, Inc. | $677 |
| Novartis Pharmaceuticals Corporation | $181 |
| Lundbeck LLC | $135 |
| Tanabe Pharma America, Inc. | $116 |
| Compensation for services other than consulting (speaking, faculty) | $40,913 |
|---|---|
| Honoraria | $9,788 |
| Food and Beverage | $4,615 |
| Travel and Lodging | $1,376 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,413 |
| AbbVie Inc. Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,250 |
| Pfizer Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) ZAVZPRET · PAIN | $3,150 |
| Pfizer Inc. Jul 11, 2025 | Compensation for services other than consulting (speaking, faculty) ZAVZPRET · PAIN | $3,150 |
| Axsome Therapeutics, Inc. Oct 9, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Axsome Therapeutics, Inc. Oct 30, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Axsome Therapeutics, Inc. Nov 6, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Axsome Therapeutics, Inc. Nov 20, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Lilly USA, LLC Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,000 |
| Axsome Therapeutics, Inc. Jul 23, 2025 | Honoraria Symbravo · Neurology | $1,688 |
All 38 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. Nov 20, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| AbbVie Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $975 |
| Lilly USA, LLC Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Axsome Therapeutics, Inc. Nov 6, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| Axsome Therapeutics, Inc. Oct 30, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| Lilly USA, LLC Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Lilly USA, LLC Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Lilly USA, LLC Oct 22, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Axsome Therapeutics, Inc. Oct 9, 2025 | Honoraria Symbravo · Neurology | $2,025 |
| AbbVie Inc. Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $975 |
| Lilly USA, LLC Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,000 |
| Lilly USA, LLC Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| Axsome Therapeutics, Inc. Jul 23, 2025 | Honoraria Symbravo · Neurology | $1,688 |
| Lilly USA, LLC Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| Pfizer Inc. Jul 11, 2025 | Compensation for services other than consulting (speaking, faculty) ZAVZPRET · PAIN | $3,150 |
| Lilly USA, LLC Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,400 |
| Lilly USA, LLC Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Pfizer Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) ZAVZPRET · PAIN | $3,150 |
| Lilly USA, LLC Jun 26, 2025 | Travel and Lodging travel to MALABAR, FL · in-kind | $226 |
| AbbVie Inc. Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,250 |
| Lilly USA, LLC May 12, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC May 12, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| Lilly USA, LLC May 7, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Lilly USA, LLC Apr 23, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,413 |
| Lilly USA, LLC Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| AbbVie Inc. Mar 29, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to DALLAS, TX · in-kind | $824 |
| AbbVie Inc. Mar 29, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to DALLAS, TX · in-kind | $327 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
| Lilly USA, LLC Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) | $600 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 4 companies. The companies reported $252,314 in research payments for these studies, mostly to the institutions running them.
- Study to Evaluate SAGE-324 in Participants With Essential Tremors
Sage Therapeutics, LLC - A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
Sage Therapeutics, LLC - A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Eli Lilly and Company · Active, not recruiting · NCT04437511 - A phase 23 randomized doubleblind placebo controlled study to evaluate the efficacy and safety of oral zavegepant in migraine prevention
Pfizer Inc. - A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
H. Lundbeck A S - Phase 3 multicenter randomized doubleblind group sequential placebocontrolled study to assess efficacy and safety of rimegepant for the treatment of migraine with or without aura in children and adolescents 6 to 18 …
Pfizer Inc. - A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Eli Lilly and Company · Completed · NCT05063539
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.